Saturday 17 October 2026
Export ARAY’s income statement to Excel — free account
Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025. In the quarter to June 2026, revenue fell 20.9%, EPS fell 300.0%, free cash flow grew 117.8% and total debt rose 18.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.16
0.01
−5.88%
Follow ARAY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(36.07%) | (70.32%) | (101.06%) | (80.08%) | |
Piotroski F-Score |
4 | 3 | 2 | 1 | |
| (4.15%) | (7.69%) | (9.90%) | (10.77%) | ||
ROIC |
(0.66%) | (8.07%) | (12.63%) | (11.25%) | |
Return on Tangible Assets |
(14.00%) | (29.15%) | (39.64%) | (39.77%) | |
Average Days of Receivables |
44.02 | 50.92 | 54.99 | 61.21 | |
Free Cash Flow per Share |
0.15 | (0.02) | (0.21) | (0.10) | |
Free Cash Flow |
17.28 | (2.66) | (25.84) | (12.84) | |
Capital Expenditures |
(5.06) | (7.21) | (6.72) | (5.86) | |
| Other line items | |||||
Cash ROIC |
6.83% | (1.21%) | (12.06%) | (5.60%) | |
Accounts Receivable Turnover |
6.17 | 5.90 | 6.00 | 5.34 | |
Accounts Payable Turnover |
6.76 | 6.48 | 6.33 | 7.79 | |
Inventory Turnover |
2.01 | 2.11 | 2.07 | 2.02 | |
Average Days of Payables |
49.63 | 50.31 | 61.44 | 50.96 | |
Days of Inventory on Hand |
182.00 | 174.51 | 182.25 | 184.80 | |
Tax Rate |
0.15 | 0.07 | 0.06 | 0.04 | |
Research and Development Expense of Revenue |
10.47% | 10.12% | 9.72% | 9.39% | |
Selling, General and Administrative Expense of Revenue |
20.66% | 20.26% | 20.61% | 20.89% | |
Share Based Compensation of Revenue |
2.30% | 2.05% | 1.77% | 1.61% | |
Interest Coverage |
(0.07) | (0.77) | (0.98) | (0.80) | |
Operating CF/Net income |
(1.16) | (0.13) | 0.41 | 0.14 | |
Depreciation/Fixed assets |
0.33 | 0.39 | 0.48 | 0.59 | |
Capex/Depreciation |
(0.53) | (0.63) | (0.48) | (0.37) | |
Revenue per Share |
3.79 | 3.61 | 3.45 | 3.28 | |
Operating CF per Share |
0.19 | 0.04 | (0.15) | (0.06) | |
Capex per Share |
(0.04) | (0.06) | (0.05) | (0.05) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.01 |
Columns are period end dates